Effect of SGLT-2 inhibitors on hepatic steatosis and fibrosis in patients with type 2 diabetes mellitus and MASLD. UOC [Internet]. 2026 May 21 [cited 2026 Jun. 21];(1). Available from: https://openconf.uz/conf/article/view/110